Skip to content

Insider · CIK 0001851633

Alex Hammacher

director

Files at BRNS (Barinthus Biotherapeutics plc.). First filing -, latest -.

Alex Hammacher files SEC Form 4 as director at BRNS (Barinthus Biotherapeutics plc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Alex Hammacher has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 9, 2026BRNS
Barinthus Biotherapeutics plc.
DDisposition to issuer
Ordinary Shares
-3,000--034 d ago
Sep 9, 2026BRNS
Barinthus Biotherapeutics plc.
DDisposition to issuer
Share Option (Right to Buy)derivative
-34,328$0.00$0034 d ago
Sep 9, 2026BRNS
Barinthus Biotherapeutics plc.
DDisposition to issuer
Share Option (Right to Buy)derivative
-18,604$0.00$0034 d ago
Sep 9, 2026BRNS
Barinthus Biotherapeutics plc.
DDisposition to issuer
Share Option (Right to Buy)derivative
-19,197$0.00$0034 d ago
Sep 9, 2026BRNS
Barinthus Biotherapeutics plc.
DDisposition to issuer
Share Option (Right to Buy)derivative
-19,516$0.00$0034 d ago
Sep 9, 2026BRNS
Barinthus Biotherapeutics plc.
DDisposition to issuer
Share Option (Right to Buy)derivative
-20,174$0.00$0034 d ago
Jun 10, 2025BRNS
Barinthus Biotherapeutics plc.
AGrant or award
Share Option (Right to Buy)derivative
+20,174$0.00$020,174Jun 11, 2025

Questions about Alex Hammacher

Answered from the filings on this page, as of the latest one.

Is Alex Hammacher buying or selling?

Alex Hammacher has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Alex Hammacher's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alex Hammacher has 0.

Where does Alex Hammacher file Form 4?

Alex Hammacher has filed Form 4 at BRNS (Barinthus Biotherapeutics plc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.